The Renal Disease Market is expanding rapidly due to the increasing prevalence of chronic kidney diseases (CKD), rising cases of diabetes and hypertension, and advancements in diagnostic and treatment options. Renal diseases, including acute kidney injury (AKI), CKD, and end-stage renal disease (ESRD), require continuous monitoring and treatment, driving the demand for dialysis, kidney transplants, and innovative drug therapies. The market is supported by growing healthcare investments, techn...